Membrane permeation mechanisms of 2′,3′-dideoxynucleosides
The mechanism of membrane permeation of several 2′,3′-dideoxynucleosides was investigated at 37° with human erythrocytes using an “inhibitor-stop” assay. Transport (per 5 μL cells) via the nucleoside and nucleobase carriers was assessed by inhibition of influx with dilazep and adenine, respectively....
Gespeichert in:
Veröffentlicht in: | Biochemical pharmacology 1993-08, Vol.46 (4), p.725-729 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The mechanism of membrane permeation of several 2′,3′-dideoxynucleosides was investigated at 37° with human erythrocytes using an “inhibitor-stop” assay. Transport (per 5 μL cells) via the nucleoside and nucleobase carriers was assessed by inhibition of influx with dilazep and adenine, respectively. Mechanisms of cellular entry were highly individualized: 2′,3′-dideoxyadenosine and 3′-deoxythymidin-2′-ene via nonfacilitated diffusion, with high rates; 2′,3′-dideoxyguanosine mainly via the nucleobase carrier (
K
m
= 390
μM,
V
max = 16 pmol/sec); 2′,3′-dideoxynisine by both nucleobase (
K
m
850
μM,
V
max = 2.7 pmol/sec) and nucleoside (
K
m
= 7.4 mM,
V
max = 16 pmol/sec) carriers, with a low rate of nonfacilitated diffusion; and 2′,3′-dideoxycytidine, equally by the nucleoside carrier (
K
m
= 23 mM,
V
max = 65 pmol/sec) and by nonfacilitated diffusion, with a low rate. These results demonstrate that the nucleobase carrier plays an important role in the influx of two of these dideoxynucleosides and that nonfacilitated diffusion is not necessarily the chief mode of membrane permeation of this class of drugs. |
---|---|
ISSN: | 0006-2952 1873-2968 |
DOI: | 10.1016/0006-2952(93)90560-J |